Active Ingredient Bosutinib
Active Ingredient Details
What is Bosutinib?
a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases; structure in first source
What is the usage for Bosutinib?
Bosutinib is used to treat a certain type of blood cancer (chronic myelogenous leukemia-CML). It works by slowing or stopping the growth of cancer cells.
How many products in the NDC database contain Bosutinib?
The NDC database has 8 products with the active ingredient Bosutinib. The following table lists all the products that have this active ingredient.
NDC Products with Bosutinib
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 46708-311 | Proprietary Name: Bosutinib | Bosutinib | Tablet, Film Coated | Oral | Alembic Pharmaceuticals Limited | ACTIVE | |
| 46708-312 | Proprietary Name: Bosutinib | Bosutinib | Tablet, Film Coated | Oral | Alembic Pharmaceuticals Limited | ACTIVE | |
| 54893-0041 | Proprietary Name: | Bosutinib | Powder | Msn Laboratories Private Limited | ACTIVE | ||
| 54893-0042 | Proprietary Name: | Bosutinib | Powder | Msn Laboratories Private Limited | ACTIVE | ||
| 62332-311 | Proprietary Name: Bosutinib | Bosutinib | Tablet, Film Coated | Oral | Alembic Pharmaceuticals Inc. | ACTIVE | |
| 62332-312 | Proprietary Name: Bosutinib | Bosutinib | Tablet, Film Coated | Oral | Alembic Pharmaceuticals Inc. | ACTIVE | |
| 62756-721 | Proprietary Name: | Bosutinib | Powder | Sun Pharmaceutical Industries, Inc. | ACTIVE | ||
| 68554-0161 | Proprietary Name: | Bosutinib | Powder | Hetero Labs Limited | ACTIVE |
